Patents Assigned to ARCTIC PHARMA AS
  • LDHA activity inhibitors
    Patent number: 11142520
    Abstract: The invention provides compounds of formula (I), stereoisomers, tautomers, pharmaceutically acceptable salts and prodrugs thereof: (I) wherein A1 to A6 and R1 to R4 are as defined herein. Such compounds are suitable for use in the treatment or prevention of diseases or conditions which are mediated by the activation of lactate dehydrogenase A (LDHA), for example cancer.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: October 12, 2021
    Assignee: ARCTIC PHARMA AS
    Inventors: Jo Klaveness, Bora Sieng, Steffi Lundvall, Claudia Alejandra Bøen, Kathrin Hnida